Argent Biopharma Limited has released a press release.
New EU Sales Agreements Signed For MGC Derma
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Argent Biopharma
- Successful MXC First Cannabinoid Production
- European API Extraction Facility Completed
- Placement of $10m Closed Significantly Oversubscribed
- Australian Legislation Changes Fast Track MXC
- Cannabinoid Extraction Facility On Target Q2 Production
Later from Argent Biopharma
- Strategic Agreement Signed with RMIT
- CEO Appointment
- Positive MGC Derma Clinical Test Results
- EU Medical Cannabis License Granted with Strategic Agreement
- First European Distribution Deal Signed for API Products
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma